Long-term treatment persistence and maintained reduction of LDL-cholesterol levels with evolocumab over 30 months: Results from the Spanish cohort of the European prospective HEYMANS study

Authors:

Abstract
No abstract available
Funding Information
  • Amgen

This publication has 24 references indexed in Scilit: